Financial Metrics Exploration: Understanding Karyopharm Therapeutics Inc (KPTI) Through Ratios

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.66 million shares were traded. KPTI stock price reached its highest trading level at $1.08 during the session, while it also had its lowest trading level at $1.02.

Ratios:

Our analysis of KPTI’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.32 and its Current Ratio is at 3.37.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on January 19, 2023, initiated with a Overweight rating and assigned the stock a target price of $8.

On November 04, 2022, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $7 to $10.

JP Morgan Upgraded its Underweight to Neutral on February 09, 2022, while the target price for the stock was maintained at $8.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 22 ’24 when Rangwala Reshma sold 6,789 shares for $1.17 per share. The transaction valued at 7,943 led to the insider holds 342,931 shares of the business.

Paulson Richard A. sold 3,563 shares of KPTI for $4,596 on Apr 04 ’24. The President and CEO now owns 1,157,273 shares after completing the transaction at $1.29 per share. On Mar 05 ’24, another insider, Paulson Richard A., who serves as the President and CEO of the company, sold 3,573 shares for $1.30 each. As a result, the insider received 4,645 and left with 1,160,836 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KPTI now has a Market Capitalization of 123453952 and an Enterprise Value of 240023104. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.85. Its current Enterprise Value per Revenue stands at 1.644 whereas that against EBITDA is -1.861.

Stock Price History:

Over the past 52 weeks, KPTI has reached a high of $3.87, while it has fallen to a 52-week low of $0.62. The 50-Day Moving Average of the stock is -19.75%, while the 200-Day Moving Average is calculated to be -10.28%.

Shares Statistics:

KPTI traded an average of 1.79M shares per day over the past three months and 1279360 shares per day over the past ten days. A total of 114.92M shares are outstanding, with a floating share count of 107.03M. Insiders hold about 8.10% of the company’s shares, while institutions hold 64.72% stake in the company. Shares short for KPTI as of 1713139200 were 23560996 with a Short Ratio of 13.15, compared to 1710460800 on 23131558. Therefore, it implies a Short% of Shares Outstanding of 23560996 and a Short% of Float of 20.66.

Most Popular

[the_ad id="945"]